Read what I quoted I was referring to the speed they are applying for approval and not wasting years unnecessarily as NWBO management has. At this speed, NVCR will have submitted the request for approval for lung cancer faster than NWBO has for GBM which data was locked 2 years 3 months ago and counting. But hey Linda is still scanning papers, she is too busy to submit an FDA request for approval.
I dont know anything about their data and the way they have concluded they improved OS for lung cancer patients and neither do you so you can NOT claim their data/trial is crap as you do know. Perhaps their lung cancer trial was crap perhaps not, their GBM trial certainly was.
Novocure plans to release the full results of the LUNAR study at a future medical conference